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Background: Cardiac MR stress perfusion remains a qualitative technique in clinical practice due to technical and postpro-
cessing challenges. However, automated inline perfusion mapping now permits myocardial blood ﬂow (MBF, ml/g/min)
quantiﬁcation on-the-ﬂy without user input.
Purpose: To investigate the diagnostic performance of this novel technique in detecting occlusive coronary artery disease
(CAD) in patients scheduled to undergo coronary angiography.
Study Type: Prospective, observational.
Subjects: Fifty patients with suspected CAD and 24 healthy volunteers.
Field Strength: 1.5T.
Sequence: "Dual" sequence multislice 2D saturation recovery.
Assessment: All patients underwent cardiac MR with perfusion mapping and invasive coronary angiography; the healthy
volunteers had MR with perfusion mapping alone.
Statistical Tests: Comparison between numerical variables was performed using an independent t-test. Receiver operator
characteristic (ROC) curves were generated for transmyocardial, endocardial stress MBF, and myocardial perfusion reserve
(MPR, the stress:rest MBF ratio) to diagnose severe (>70%) stenoses as measured by 3D quantitative coronary angiography
(QCA). ROC curves were compared by the method of DeLong et al.
Results: Compared with volunteers, patients had lower stress MBF and MPR even in vessels with <50% stenosis (2.00
vs. 3.08 ml/g/min, respectively). As stenosis severity increased (<50%, 50–70%, >70%), MBF and MPR decreased. To diagnose
occlusive (>70%) CAD, endocardial and transmyocardial stress MBF were superior to MPR (area under the curve 0.92 [95% CI
0.86–0.97] vs. 0.90 [95% CI 0.84–0.95] and 0.80 [95% CI 0.72–0.87], respectively). An endocardial threshold of 1.31 ml/g/min
provided a per-coronary artery sensitivity, speciﬁcity, positive predictive value (PPV), and negative predictive value (NPV) of
90%, 82%, 50%, and 98%,with a per-patient diagnostic performance of 100%, 66%, 57%, and 100%, respectively.
Data Conclusion: Perfusion mapping can diagnose occlusive CAD with high accuracy and, in particular, high sensitivity
and NPV make it a potential "rule-out" test.
Level of Evidence: 1
Technical Efﬁcacy Stage: 2
J. MAGN. RESON. IMAGING 2019;50:756–762.
CORONARY ARTERY DISEASE (CAD) remains amajor global cause of morbidity and mortality.1 Func-
tional noninvasive testing permits CAD detection by
identifying areas of impaired myocardial perfusion at stress
that may beneﬁt from revascularization.2–4 This can help to
reduce the invasive angiography rates and better targets
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invasive strategies. However, for effective care noninvasive
testing needs to be accurate.5
Myocardial perfusion cardiac magnetic resonance imaging
(MRI) is a well-validated functional ischemia test and is widely
used.6,7 Images are acquired during the ﬁrst myocardial passage
of a gadolinium-based contrast agent during vasodilator stress
and often repeated at rest. Areas of hypoperfusion at stress
indicate ischemia. However, in clinical practice interpretation
of myocardial perfusion MRI is mostly qualitative, relying on
an experienced operator to identify true perfusion defects.
Quantifying myocardial blood ﬂow (MBF) has the potential to
be less operator-dependent8 and to better detect balanced
ischemia in three-vessel disease.9 Fully quantitative perfusion
using positron emission tomography (PET) has shown addi-
tional prognostic beneﬁts in CAD and cardiomyopathy.10,11
However, PET uses ionizing radiation, is more expensive, and
there is often limited availability in many regions.
Developing quantitative perfusion MRI for clinical use has
been challenging. Dual bolus or dual sequence approaches12–14
are needed for quantiﬁcation in order to obtain the arterial input
function. Subsequently, there is laborious operator input, often
requiring the contouring of up to 300 images per patient. There-
fore, the technique has not transitioned to clinical care. Ofﬂine
techniques are improving, but operator input and image porting
to custom tools remains necessary.15 Recently, these limitations
have been effectively overcome with inline "Perfusion Map-
ping."16 This method uses a dual sequence approach, with respi-
ratory motion correction and signal nonlinearity correction.
Exploiting modern computing hardware, there is automatic
identiﬁcation of the left ventricle (LV) blood pool and generation
of the arterial input function. A sophisticated blood tissue
exchange model delivers pixel-by-pixel blood ﬂow quantiﬁcation
solved using partial differential equations.17 Within ~90 sec-
onds, perfusion maps are outputted on the scanner, where each
voxel color encodes myocardial blood ﬂow (in ml/g/min, Fig. 1).
The technique has been validated against PET, showing good
correlation.18,19
We investigated the diagnostic performance of perfusion
mapping in patients suspected of having coronary disease.
Materials and Methods
The study was approved by the National Health Service Research
Ethics Committee (NHS REC) and Health Research Authority
(HRA) and conducted in accordance with the Declaration of
Helsinki. All subjects provided written, informed consent. Fifty
patients with chest pain and scheduled for invasive coronary angi-
ography were prospectively recruited. All patients underwent
MRI with automated inline perfusion mapping prior to invasive
angiography. The exclusion criteria were previous coronary artery
bypass grafting, chronic kidney disease stage IV and V (estimated
glomerular ﬁltration rate [eGFR] <30 mmol/l), overt cardiomy-
opathy (hypertrophic, arrhythmogenic, dilated, amyloid),
contraindication to MRI, or contraindication to adenosine.
A healthy volunteer cohort of 24 individuals with no cardiac
symptoms, medications, or comorbidities was also recruited
prospectively.
MRI Protocol
MRI scans were performed at 1.5 T (Aera, Siemens Healthineers,
Erlangen, Germany) using a standard clinical protocol.20 The proto-
col consisted of cine imaging, stress and rest perfusion, and late
gadolinium enhancement (LGE). For the perfusion imaging, adeno-
sine was infused for 4 minutes at a dose of 140 μg/kg/min
(increased to 175 μg/kg/min for a further 2 min if less than 10%
heart rate increase or no symptoms). At peak stress a gadolinium-
based contrast agent (gadoterate meglumine, Dotarem, Guerbet,
Paris, France) was injected into a peripheral vein at 4 ml/s at a dose
of 0.05 mmol/kg and 60 dynamic images were acquired for three
LV short-axis slices. Rest perfusion images were acquired after an
interval of 6–10 minutes. Perfusion mapping was performed as pre-
viously described16 and implemented on the scanner using the Gad-
getron streaming software image reconstruction framework.21
The perfusion maps were analyzed using commercially available
software (CVI42, Circle Cardiovascular Imaging, Calgary, Canada).
This consisted of simply contouring the endo- and epicardial on three
slices and deﬁning the right ventricular (RV) insertion points. The
software created a border 10% offset and drew the 16 segment Ameri-
can Heart Association (AHA) model.22 By placing the epicardial offset
to 50%, an endocardial and epicardial MBF was also obtained
(Fig. 2). The mean MBF of the two myocardial segments with the
lowest ﬂow in each coronary territory was calculated to ensure that
there was no bias against distal coronary stenosis.23 The MBF was cal-
culated in this way for each coronary territory at stress and rest and
the ratio of these gave the myocardial perfusion reserve (MPR).
Segments with subendocardial and transmural LGE were excluded
from the analysis but wall motion abnormalities were not considered.
Finally, the data were analyzed on a per-patient basis and the
scan was declared abnormal if there was a reduced stress MBF/MPR
in any coronary territory.
Invasive Angiography
Invasive angiography was performed according to the standard clini-
cal protocols. The major epicardial vessels and large side branches
(intermediate, large diagonal, and large obtuse marginal) with visual
luminal stenosis >30% were reconstructed based on the angiographic
data using 3D quantitative coronary angiography (3D QCA) meth-
odology.24 This was performed using well-validated software
(QAngio XA 3D RE, Medis Specials, Leiden, The Netherlands).
Two end-diastolic angiographic projections (>25 apart) with no
overlapping or foreshortening of the segment of interest were
selected for analysis to allow accurate delineation of the lumen sil-
houette. The lumen centerline and borders were automatically
detected in both projections using an established edge detection
algorithm. Manual adjustments were made when needed by an expe-
rienced interventional cardiologist blinded to MRI results. For each
studied segment the reference lumen area, minimum lumen area and
lesion length were estimated and the diameter stenosis (DS) was
calculated. The studied lesions were grouped into three DS groups:
DS <50% (mild), DS 50–70% (moderate), and DS >70% (severe).
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Statistical Analysis
Statistical analysis was performed in SPSS (IBM SPSS statistics,
v. 25.0, Armonk, NY). Numerical variables are presented as mean 
standard deviation and categorical variables as absolute values and
percentages. Comparison between numerical variables was performed
using an independent t-test while the chi-square test was used for
categorical variables. P < 0.05 was considered statistically signiﬁcant.
Receiver operator characteristic (ROC) curves were calculated to
determine the accuracy of the perfusion maps in detecting a DS
>70% in a coronary artery and determine the optimal cutoffs for
diagnosis of severe stenosis (>70%). Subsequently, the sensitivity,
speciﬁcity, positive predictive value (PPV), and negative predictive
value (NPV) in diagnosing a patient with CAD on the basis of quan-
titative perfusion was calculated. The area under the curve (AUC) of
ROC curves were compared using the method of DeLong et al.25
Results
Patient and volunteer characteristics are displayed in Table 1.
Patients were older (58.2 vs. 37.3 years, P < 0.001), a higher
proportion were male (87% vs. 50%, P = 0.003), and had
more comorbidities compared with the volunteers.
FIGURE 1: Perfusion maps in health and disease. Stress (a–c) and rest (e–g) perfusion maps for a 64-year-old healthy volunteer and a
patient with 80% stenosis of the LCx and occlusion of the RCA (i–k,m–o). The polar maps (l,p) indicate that the patient’s stress MBF
is lowest in the RCA territory (0.96 ml/g/min) and 2.09–2.70 ml/g/min in remote myocardium. The volunteer’s stress MBF
is 2.43–3.17 ml/g/min and rest MBF 0.42–0.79 ml/g/min.
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Perfusion mapping analysis was feasible in all 150 cor-
onary territories. Conversely, 3D QCA analysis was not
performed in 28 vessels, as in these cases it was not possible
to obtain two angiographic views 25 apart, with no fore-
shortening or overlapping of the segment of interest. There-
fore, 122 vessels and their corresponding myocardial
territories were included in the ﬁnal analysis. Stenosis by
3D QCA was <50% in 81 vessels, 50–70% in 20 vessels,
and > 70% in 21 vessels. Eighteen patients (40%) had at
least one vessel with a severe stenosis (>70%). The healthy
volunteer comparator cohort only had perfusion MRI and
all 72 coronary territories could be analyzed by perfusion
mapping.
Healthy volunteers had higher transmyocardial stress
MBF and MPR than patients, even in segments supplied by
vessels with <50% stenosis. Mean stress MBF was 3.07 ml/g/
min in healthy volunteers and 2.00 ml/g/min in the myocar-
dium of patients with DS <50%. As the DS increased, the
MBF and MPR decreased (Fig. 3). Rest MBF was not signiﬁ-
cantly different between volunteers (0.86 ml/g/min) and
FIGURE 2: Perfusion map analysis. An example of perfusion map analysis for a single mid-LV slice. Endocardial and epicardial borders
were manually traced, RV insertion points identiﬁed, and the LV segmented. Left panel: The borders are offset by 10% to minimize
partial volume effects at the blood-myocardial and myocardial-pericardial borders. Right panel: The epicardial border is offset by
50% to measure endocardial ﬂow.
TABLE 1. Patient and Volunteer Characteristics
Patients (n = 50) Volunteers (n = 24) P value
Age (years) 58.2 37.3 <0.001
Gender (% male) 86 50 0.003
Height (cm) 172 173 0.556
Weight (kg) 83 77 0.083
BSA 1.99 1.92 0.181
LVEDV (ml) 145 153 0.389
LV mass (g) 116 103 0.090
EF (%) 66 66 0.924
Diabetes (%) 16 0 0.004
Hypertension (%) 58 0 <0.001
Hypercholesterolemia (%) 68 0 <0.001
Smoker (%) 46 0 <0.001
AF (%) 6 0 0.226
Patients were signiﬁcantly older, a greater proportion were male, and they had more comorbidities than the volunteers. Body surface area
(BSA), left ventricular (LV), EDV (end diastolic volume), ejection fraction (EF), atrial ﬁbrillation (AF).
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remote myocardium (0.80 ml/g/min) or ischemic myocar-
dium (0.77 ml/g/min), (P = 0.32 and P = 0.24, respectively).
ROC curves were calculated to determine the diagnos-
tic accuracy of endocardial stress, transmyocardial stress
MBF, and MPR for >70% stenoses per vessel (Fig. 4).
Segments with LGE were excluded (eight myocardial terri-
tories). The accuracy of endocardial stress MBF (AUC
0.92, 95% conﬁdence interval [CI] 0.87–0.97) was not sta-
tistically signiﬁcantly different (P = 0.051) from transmyo-
cardial stress MBF (AUC 0.90, 95% CI 0.84–0.95).
Endocardial and transmyocardial stress was more accurate
than MPR (AUC 0.81, 95% CI 0.71–0.91, P = 0.01 and
P = 0.04, respectively).
An optimal diagnostic threshold for each parameter was
determined from the ROC curves. The optimal threshold for
endocardial stress on a per-vessel basis was 1.31 ml/g/min,
providing sensitivity, speciﬁcity, PPV, and NPV of 90%,
85%, 55%, and 98%, respectively; for transmyocardial MBF
it was 1.50 ml/g/min, providing 90%, 78%, 47%, and 97%,
respectively.
A per-patient-based analysis (rather than a single coro-
nary vessel basis) was performed on the 45 patients where
there was full QCA or where vessels that could not undergo
QCA were obviously visually normal. The optimal cutoff
point to declare the study abnormal for endocardial stress
MBF was <1.31 ml/g/min with per-patient sensitivity, speci-
ﬁcity, PPV, and NPV of 100%, 74%, 73%, and 100%,
respectively. Using the optimal cutoff point MBF of
<1.5 ml/g/min in any coronary territory for transmyocardial
stress, the sensitivity, speciﬁcity, PPV, and NPV was 100%,
70%%, 70%, and 100%, respectively.
Discussion
In this study we demonstrated that stress perfusion MRI with
automated inline perfusion mapping is feasible and accurate
for the detection of signiﬁcant CAD. Stress endocardial and
transmyocardial MBF were the most accurate parameters,
while MPR was less accurate. On both a coronary territory
and whole patient basis, perfusion mapping was highly sensi-
tive, and adequately speciﬁc with a high NPV. In our study,
when MBF in every myocardial territory was >1.5 ml/g/min
there was no occlusive CAD and this can be immediately
visualized on the color perfusion maps. The concordance with
angiography is important because it provides conﬁdence in
the technique for transition to clinical practice and comple-
ments the MRI validation studies against PET.18,19
One of the major advantages of fully quantitative perfu-
sion is that it removes the subjectivity in the interpretation of
perfusion MRI. Perfusion mapping is a further step forward
in that it is does not require the laborious postprocessing
associated with other dual sequence techniques. As it uses a
single contrast bolus approach, it is also suitable for the clini-
cal workﬂow where dual bolus techniques can be cumber-
some. These factors mean that perfusion mapping is well
placed to be introduced into clinical MR. With this in mind,
a key ﬁnding in our study is the high diagnostic accuracy of
perfusion mapping. Using a completely automated approach,
perfusion mapping achieves similar accuracies for the diagno-
sis of CAD to that achieved by expert visual reads in recent
landmark studies such as CE-MARC.7 This is an advance on
what has been done previously.
Furthermore, the output of the color perfusion maps is
another advantage of the approach. In a similar way that para-
metric mapping has improved tissue characterization,26 with
FIGURE 3: Myocardial blood ﬂow and perfusion reserve in
volunteers and patients. Stress MBF is lower for patients than
volunteers (P < 0.001), even in territories with <50% stenosis.
Stress MBF is signiﬁcantly lower in vessels with >70% stenosis
than <50% (P < 0.001) and 50–70% stenosis (P < 0.001). MPR is
lower in patients than volunteers (P = 0.009). MPR is lower in
vessels with >70% stenosis than <50% (P < 0.001) and 50–70%
stenosis (P = 0.03).
FIGURE 4: ROC curves plotting the sensitivity against 1-
speciﬁcity for transmyocardial stress MBF, subendocardial MBF,
and MPR in diagnosing a coronary stenosis >70%. Endocardial
stress and transmyocardial stress are superior to MPR (P = 0.01
and P = 0.04, respectively).
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an appropriate color look-up table, perfusion mapping gives
an easy, instantaneous visual representation of perfusion. As
there was a very high NPV observed in this study, with the
use of an appropriate color look-up table, an observer can
rapidly appreciate a normal scan. The high NPV of a normal
quantitative perfusion study is also reﬂected in the PET
literature.27
A degree of variation in absolute MBF and MPR is to
be expected in any given population and is seen in all nonin-
vasive tests, with heterogeneity introduced by variations in
study protocols, sequences, and contrast or tracers. However,
despite this, the MBF values we found in our study (both
optimal cutoff values and our healthy volunteer results) are
similar to those observed in the PET literature.27
It has been argued by some that that the MPR (the
ratio of stress MBF to rest MBF) would be the best myocar-
dial parameter of occlusive epicardial CAD. However, in our
study (and others27), this was not the case. We found that it
is the peak MBF that correlated best. MPR seems to fall short
because the denominator of MPR, rest ﬂow, is independently
autonomically regulated and inﬂuenced by factors such as
gender, resting heart rate, contractility, and wall stress that
are not related to peak ﬂow.
Areas of ischemia from an epicardial stenosis >70% have
lower measurable MBF, which is readily visualized on the
perfusion maps. However, perfusion is not absolutely speciﬁc
to epicardial coronary ﬂow. This may explain why the speci-
ﬁcity and PPV were lower than the sensitivity and NPV in
our study. "False positives" when using a ﬁxed threshold
approach may be a result of microvascular disease,28 submaxi-
mal vasodilatation, or a combination of these factors. Epicar-
dial coronary disease and microvascular disease are not
mutually exclusive and PET studies have shown that myocar-
dial perfusion falls with an increasing coronary calcium
score.29 Therefore, it is not surprising that there were patients
in our cohort who had a signiﬁcant coronary stenosis in a sin-
gle vessel but additionally had impaired perfusion in other
areas of the myocardium, perhaps due to microvascular dis-
ease. A result such as this would have resulted in a false posi-
tive on per-vessel analysis but a true positive on per-patient
analysis.
There are limitations to our study, with our relatively
small sample size and the inherent limitations in comparing
an anatomical test (3D QCA) with a functional test (perfu-
sion MRI). "False positive" perfusion maps may have actually
been "false negative" 3D QCA analysis and vice versa; thus,
artiﬁcially lowering our diagnostic accuracy. QCA is not a
perfect truth standard but has been commonly used as an
endpoint in major perfusion MRI trials.4,7 This may also
explain why there was only a trend towards signiﬁcance in
MBF between mild disease (<50%) and moderate disease
(50–70%). Also, patients with cardiomyopathy were excluded
from our study. These patients commonly have reduced
myocardial perfusion30,31 and so the results presented here
may not be applicable to patients with cardiomyopathy.
In summary, cardiac MRI with automated inline perfu-
sion mapping is easy to implement and accurate for the detec-
tion of epicardial occlusive CAD with high sensitivity, strong
negative predictive values, and adequate speciﬁcity. Practi-
cally, normal perfusion maps (all pixels encoding an MBF
above the aforementioned cutoff values) are instantly recog-
nizable and can rule out occlusive CAD, making this an ideal
test to integrate into the clinical workﬂow.
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